Measles virus infection in adults induces production of IL-10 and is associated with increased CD4+CD25+ regulatory T cells

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 7356-7366

  Yu, Xue Lian ^a,d   Cheng, Yu Ming ^a   Shi, Bi Sheng ^a   Qian, Fang Xing ^c   Wang, Feng Bin ^a   Liu, Xi Nian ^a   Yang, Hai Ying ^a   Xu, Qing Nian ^a   Qi, Tang Kai ^a   Zha, Li Jun ^a   Yuan, Zheng Hong ^a   Ghildyal, Reena ^a,b  

^a FUDAN UNIVERSITY   (China)

^b MONASH UNIVERSITY   (Australia)

^c Changning Hospital   (China)

^d Shanghai Municipal Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; MESSENGER RNA; CD14 ANTIGEN; VIRUS ANTIBODY;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; BLOOD SAMPLING; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INNATE IMMUNITY; MALE; MEASLES; MEASLES VIRUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL; VIRUS ISOLATION; BIOSYNTHESIS; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOLOGY; MACROPHAGE; METABOLISM; MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, CD14; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; MEASLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 58149184308     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.7356     Document Type: Article

References (57)

1. Aiqiang, X., F. Zijian, X. Wenbo, W. Lixia, G. Wanshen, X. Qing, S. Haijun, L. A. Lee, and L. Xiaofeng. 2003. Active case-based surveillance for measles in China: lessons learned from Shandong and Henan provinces. J. Infect. Dis. 187 (Suppl. 1): S258-S263. (Pubitemid 36583964)
2. Williams, J. R., and P. Manfredi. 2004. Ageing populations and childhood infections: the potential impact on epidemic patterns and morbidity. Intern. J. Epidemiol. 33: 566-572.
3. Centers for Disease Control and Prevention. 2005. Progress in reducing measles mortality: worldwide, 1999-2003. Morbid. Mortal. Wkly. Rep. 54: 200-203.
4. Izurieta, H., L. Venczel, V. Dietz, G. Tambini, O. Barrezueta, P. Carrasco, R. Quiroga, J. Andre, C. Castillo-Solorzano, M. Brana, et al. 2003. Monitoring measles eradication in the region of the Americas: critical activities and tools. J. Infect. Dis. 187 (Suppl. 1): S133-S139. (Pubitemid 36583945)
5. Muller, C. P., J. R. Kremer, J. M. Best, I. Dourado, H. Triki, and S. Reef. 2007. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005. Vaccine 25: 1-9.
6. Dhiman, N., I. G. Ovsyannikova, A. L. Oberg, D. E. Grill, R. M. Jacobson, and G. A. Poland. 2005. Immune activation at effector and gene expression levels after measles vaccination in healthy individuals: a pilot study. Hum. Immunol. 66: 1125-1136.
7. Gabutti, G., M. C. Rota, S. Salmaso, B. M. Bruzzone, A. Bella, and P. Crovari. 2002. Epidemiology of measles, mumps, and rubella in Italy. Epidemiol. Infect. 129: 543-550.
8. Williams, J. R., and P. Manfredi. 2004. Ageing populations and childhood infections: the potential impact on epidemic patterns and morbidity. Int. J. Epidemiol. 33: 566-572.
9. Xiaojue, L., X. Hua, and Z. Jiaxin. 2005. Analysis on the clinical symptom of 224 adult measles patients. Chin. J. Exp. Clin. Virol. 19: 99.
10. Yi, L., H. Youwei, W. Xiaohong, and Z. Qirong. 2000. New characterize of measles epidemic during 1990's, in Shanghai. Chin. J. Clin. Ped. 18: 142-144.
11. Zheng, Y. F., X. N. Liu, Q. Huang, Y. Ling, H. Q. Sun, and H. Z. Lu. 2005. Clinical analysis of 102 measles patients in Shanghai at 2005. World J. Infect. 5: 497-498.
12. Moss, W. J., M. O. Ota, and D. E. Griffin. 2004. Measles: immune suppression and immune responses. Int. J. Biochem. Cell Biol. 36: 1380-1385.
13. Schneider-Schaulies, J., L. M. Dunster, S. Schneider-Schaulies, and V. ter Meulen. 1995. Pathogenetic aspects of measles virus infections. Vet. Microbiol. 44: 113-125.
14. Griffin, D. E., R. T. Johnson, V. G. Tamashiro, T. R. Moench, E. Jauregui, I. Lindo de Soriano, and A. Vaisberg. 1987. In vitro studies of the role of monocytes in the immunosuppression associated with natural measles virus infections. Clin. Immunol. Immunopathol. 45: 375-383.
15. Esolen, L. M., B. J. Ward, T. R. Moench, and D. E. Griffin. 1993. Infection of monocytes during measles. J. Infect. Dis. 168: 47-52.
16. Griffin, D. E., T. R. Moench, R. T. Johnson, I. Lindo de Soriano, and A. Vaisberg. 1986. Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. Clin. Immunol. Immunopathol. 40: 305-312.
17. Hahm, B., N. Arbour, D. Naniche, D. Homann, M. Manchester, and M. B. Oldstone. 2003. Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule. J. Virol. 77: 3505-3515. (Pubitemid 36297270)
18. Niewiesk, S., M. Gotzelmann, and V. ter Meulen. 2000. Selective in vivo suppression of T lymphocyte responses in experimental measles virus infection. Proc. Natl. Acad. Sci. USA 97: 4251-4255.
19. Ryon, J. J., W. J. Moss, M. Monze, and D. E. Griffin. 2002. Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles. Clin. Diagn. Lab. Immunol. 9: 994-1003.
20. Vinante, F., M. Krampera, L. Morosato, A. Rigo, S. Romagnani, and G. Pizzolo. 1999. Peripheral T lymphocyte cytokine profile (IFN-γ, IL-2, IL-4) and CD30 expression/release during measles infection. Haematologica 84: 683-689. (Pubitemid 29424402)
21. Salonen, R., J. Ilonen, and A. A. Salmi. 1989. Measles virus inhibits lymphocyte proliferation in vitro by two different mechanisms. Clin. Exp. Immunol. 75: 376-380. (Pubitemid 19109983)
22. Griffin, D. E., and B. J. Ward. 1993. Differential CD4 T cell activation in measles. J. Infect. Dis. 168: 275-281.
23. Hoffman, S. J., F. P. Polack, D. A. Hauer, and D. E. Griffin. 2003. Measles virus infection of rhesus macaques affects neutrophil expression of IL-12 and IL-10. Viral Immunol. 16: 369-379.
24. Hari, Y., A. Urwyler, M. Hurni, N. Yawalkar, C. Dahinden, T. Wendland, L. R. Braathen, L. Matter, and W. J. Pichler. 1999. Distinct serum cytokine levels in drug- and measles-induced exanthema. Int. Arch. Allergy. Immunol. 120: 225-229.
25. Yokota, S., H. Saito, T. Kubota, N. Yokosawa, K. Amano, and N. Fujii. 2003. Measles virus suppresses interferon-α signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon- α receptor complex. Virology 306: 135-146. (Pubitemid 36293404)
26. Mills, K. H. 2004. Regulatory T cells: friend or foe in immunity to infection? Nat. Rev. Immunol. 4: 841-855. (Pubitemid 39490760)
27. Holden, H. Y., R. K. Oldham, J. R. Ortaldo, and R. B. Herberman. 1976. Cryopreservation of the functional activity of normal and immune leukocytes and of tumor cells. In In vitro Methods in Cell-Mediated and Tumor Immunity. B. R. Bloom and J. R. David, eds. Academic Press, New York, p. 723.
28. Centers for Disease Control and Prevention. 2002. Standard Protocols for Molecular Epidemiology, Measles Virus Section. Centers for Disease Control and Prevention, Atlanta, pp. 38-50.
29. Yu, X. L., F. X. Qian, Y. Z. Sheng, D. S. Xie, D. Li, Q. Huang, Y. Zhang, Z. H. Yuan, and R. Ghildyal. 2007. Clinical and genetic characterization of measles viruses isolated from adult patients in Shanghai in 2006. J. Clin. Virol. 40: 146-151.
30. Hierholzer, J. G., and R. A. Killington. 1996. Virus isolation and quantitation. In Virology Methods Manual. B. W. J. Mahy and H. O. Kangro, eds. Academic Press, San Diego, pp. 25-46.
31. Liu, J., H. M. Wei, Z. G. Tian, J. B. Feng, and N. Song. 1999. Establishment of detecting methods of Th1/Th2 cytokine gene. Chin. J. Immunol. 15: 57-58.
32. Helin, E., R. Vainionpaa, T. Hyypia, I. Julkunen, and S. Matikainen. 2001. Measles virus activates NF-κB and STAT transcription factors and production of IFN-α/β and IL-6 in the human lung epithelial cell line A549. Virology 290: 1-10. (Pubitemid 33111870)
33. Jaye, A., C. A. Herberts, S. Jallow, S. Atabani, M. R. Klein, P. Hoogerhout, M. Kidd, C. A. van Els, and H. C. Whittle. 2003. Vigorous but short-term γ interferon T-cell responses against a dominant HLA-A*02-restricted measles virus epitope in patients with measles. J. Virol. 77: 5014-5016. (Pubitemid 36402852)
34. Okada, H., F. Kobune, T. A. Sato, T. Kohama, Y. Takeuchi, T. Abe, N. Takayama, T. Tsuchiya, and M. Tashiro. 2000. Extensive lymphopenia due to apoptosis of uninfected lymphocytes in acute measles patients. Arch. Virol. 145: 905-920. (Pubitemid 30332610)
35. Roscic-Mrkic, B., R. A. Schwendener, B. Odermatt, A. Zuniga, J. Pavlovic, M. A. Billeter, and R. Cattaneo. 2001. Roles of macrophages in measles virus infection of genetically modified mice. J. Virol. 75: 3343-3351. (Pubitemid 32225897)
36. + regulatory T cells express lower levels of the IL-7 receptor α chain (CD127), allowing consistent identification and sorting of live cells. J. Immunol. Methods 319: 41-52.
37. Moss, W. J., J. J. Ryon, M. Monze, and D. E. Griffin. 2002. Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J. Infect. Dis. 186: 879-887.
38. + T cells during cure of colitis. J. Immunol. 177: 5852-5860.
39. + cells by the TIRC7 surface marker. J. Immunol. 180: 6054-6063.
40. McKimm, J., and F. Rapp. 1977. Variation in ability of measles virus plaque progeny to induce interferon. Proc. Natl. Acad. Sci. USA 74: 3056-3059. (Pubitemid 8132492)
41. Bolt, G., K. Berg, and M. Blixenkrone-Moller. 2002. Measles virus-induced modulation of host-cell gene expression. J. Gen. Virol. 83: 1157-1165. (Pubitemid 34477289)
42. Griffin, D. E., B. J. Ward, E. Jauregui, R. T. Johnson, and A. Vaisberg. 1990. Immune activation during measles: interferon-γ and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J. Infect. Dis. 161: 449-453.
43. Dhiman, N., I. G. Ovsyannikova, J. E. Ryan, R. M. Jacobson, R. A. Vierkant, V. S. Pankratz, S. J. Jacobsen, and G. A. Poland. 2005. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clin. Exp. Immunol. 142: 498-504. (Pubitemid 41719846)
44. Shi, T., W. Z. Liu, F. Gao, G. Y. Shi, and S. D. Xiao. 2005. Intranasal CpG-oligodeoxynucleotide is a potent adjuvant of vaccine against Helicobacter pylori, and T helper 1 type response and interferon-γ correlate with the protection. Helicobacter. 10: 71-79. (Pubitemid 40269375)
45. Sommer, F., H. Wilken, G. Faller, and M. Lohoff. 2004. Systemic Th1 immunization of mice against Helicobacter pylori infection with CpG oligodeoxynucleotides as adjuvants does not protect from infection but enhances gastritis. Infect. Immun. 72: 1029-1035. (Pubitemid 38166685)
46. Gans, H. A., Y. Maldonado, L. L. Yasukawa, J. Beeler, S. Audet, M. M. Rinki, R. DeHovitz, and A. M. Arvin. 1999. IL-12, IFN-γ and T cell proliferation to measles in immunized infants. J. Immunol. 162: 5569-5575.
47. Li, H., C. J. Hickman, R. F. Helfand, H. Keyserling, L. J. Anderson, and W. J. Bellini. 2001. Induction of cytokine mRNA in peripheral blood mononuclear cells of infants after the first dose of measles vaccine. Vaccine 19: 4896-4900. (Pubitemid 32800777)
48. Chen, W., M. S. Ford, K. J. Young, and L. Zhang. 2004. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses. Cell. Mol. Immunol. 1: 328-335.
49. Bazil, V., and J. L. Strominger. 1991. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147: 1567-1574.
50. + T reg cells. J. Exp. Med. 203: 1701-1711.
51. Miyara, M., and S. Sakaguchi. 2007. Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13: 108-116. (Pubitemid 46341958)
52. Staples, K. J., M. Bergmann, P. J. Barnes, and R. Newton. 2000. Stimulus-specific inhibition of IL-5 by cAMP-elevating agents and IL-10 reveals differential mechanisms of action. Biochem. Biophys. Res. Commun. 273: 811-815.
53. Yang, X., S. Wang, Y. Fan, and X. Han. 2000. IL-10 deficiency prevents IL-5 overproduction and eosinophilic inflammation in a murine model of asthma-like reaction. Eur. J. Immunol. 30: 382-391. (Pubitemid 30098830)
54. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol. 168: 1080-1086.
55. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
56. + T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197: 111-119.
57. Okada, H., T. A. Sato, A. Katayama, K. Higuchi, K. Shichijo, T. Tsuchiya, N. Takayama, Y. Takeuchi, T. Abe, N. Okabe, and M. Tashiro. 2001. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Arch. Virol. 146: 859-874. (Pubitemid 32477402)